Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| SUMMER INFAN | SUMR | 7.23% |
| FEDERAL MOGU | FDML | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NATUS MEDICA | BABY | 5.27% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
In the latest move to do away with its non-core operations and assets, HSBC Holdings plc ( HBC - Analyst Report ) announced last week that it is planning to divest two of its U.S. insurance businesses to Bermuda-based Enstar Group Limited ( ESGR - Snapshot Report ) for $181 million in cash. Household Insurance Group Holding Company, an affiliate of HSBC, will be divesting Household Life Insurance Company and HSBC Insurance Company.
Both firms, which are to be divested, write life insurance and related products that comprise credit insurance, term life insurance, assumed reinsurance, corporate owned life insurance and annuities for the U.S. and Canadian clients. HSBC had acquired Household International Inc. in 2003 and integrated the latter with its subsidiary Household Finance Corporation.
The deal is still subject to regulatory approvals as well as other customary closing conditions. HSBC stated that the transaction is expected to be closed by early next year.
The deal is a part of HSBC’s long-term strategy to revamp its operations in order to stabilize the capital levels and improve efficiency. In May 2011, the CEO of the company had announced plans to reduce the operating expenses by $3.5 million by the end of 2013, through restructuring and contraction of its global business. Further, in August 2011, HSBC also announced its plans to trim down the workforce by 30,000 in the next two years.
With the main intention of focusing more on the fast-growing and profitable markets, HSBC has made significant progress in shedding its unprofitable and non-core operations by divesting or closing more than 35 of its operations across the globe. The major divestitures include the sale of 195 non-strategic branches in the U.S. to First Niagara Financial Group Inc. ( FNFG - Snapshot Report ) and its U.S. credit card business to Capital One Financial Corporation ( COF - Analyst Report ) .
Moreover, earlier this year, HSBC announced the sale of its general insurance businesses in Asia and Latin America for $914 million. The company will be divesting its general insurance units in Hong Kong, Singapore, Argentina and Mexico to Australia's QBE Insurance Group Ltd. and France-based AXA Group in two separate deals.
Currently, HSBC retains a Zacks #4 Rank, which translates into a short-term Sell rating. However, considering the fundamentals, we maintain a long term Neutral recommendation on the stock.
Read the full reports :
Analyst Report on HBC
Analyst Report on COF
Snapshot Report on FNFG
Snapshot Report on ESGR